A scientist who studies how dopamine works in the brain will use a $400,000 grant to investigate clues that the chemical may have a role in Alzheimer’s disease. The information could be used to shut down the degenerative process at the beginning, before patients lose brain cells and memory they will never get back. “All therapeutic treatments (for Alzheimer’s) are symptomatic. They can’t slow down the disease,” said Michael Beckstead, who works in the Aging & Metabolism Research Program at the Oklahoma Medical Research Foundation. “Once brain cells are dead, they can’t come back,” Beckstead said. “If we catch it early on before the cells really start dying off, we could develop therapies to arrest the process in its earliest stages before any cognitive damage is done.” That will require a way to diagnose Alzheimer’s sooner because it usually isn’t diagnosed until memory loss has set in. Some of the earliest symptoms are depression and apathy, which involve areas of the brain Beckstead studies. “People with depression and apathy are much more likely to develop Alzheimer’s later in life,” he said. With the new grant from the National Institute on Aging, he will be studying dopamine neurons in the brains… Read full this story
- ASU researchers seek to reduce exposure to chromium-6 in drinking water
- Bronx hotel eyed as possible Legionnaires' disease source accuses NYC of withholding information on the outbreak
- New York health officials searching for Legionnaires’ disease source amid South Bronx outbreak
- ‘Bubble skin man’ of Indonesia, Chandra Wisnu, seeks cure for disease with help from TLC documentary
- EXCLUSIVE: Gambino scion John Gotti Jr. stabbed while stopping LI fight: Source
- New mom, 33, jumps to her death from Columbia University dorm as husband tries to stop her: cop sources
- Brooklyn man dies from gunshot to buttock, cops seek daughter's boyfriend: sources
- KIDS WITH ADULT DISEASES
- Alzheimer’s path found by Columbia researchers
- The Daily Checkup: Inflammatory bowel disease is specialty for Mount Sinai father-son team
Researcher seeks to stop Alzeheimer's disease at its source have 344 words, post on oklahoman.com at July 14, 2019. This is cached page on USA Breaking News. If you want remove this page, please contact us.
